Natalia Rompoti (N Rompoti)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Venues

Journal of the European Academy of Dermatology and Venereology : JEADV

Dermatologic therapy

International journal of dermatology

National and Kapodistrian University of Athens

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National and Kapodistrian University of Athens

Greece

MD, Dr. med :: 1st Department of Dermatology-Venereology, Faculty of Medicine, “A. Sygros” Hospital for Skin and Venereal Diseases

Publications

Andrea Chiricozzi, Giulia Coscarella, Lluis L Puig, Ronald B Vender, Jensen Yeung, Y José Manuel Carrascosa, Stefano Piaserico, Paolo Gisondi, Charles Lynde, Paulo Ferreira, Pedro Mendes Bastos, Esteban Daudén, Luiz Leite, Joana Valerio, Elena Del Alcázar-Viladomiu, Eva Vilarrasa, Mar Llamas Velasco, Mario Alessandri-Bonetti, Francesco Messina, Manfredo Bruni, Eugenia Veronica Di Brizzi, Federica Ricceri, Alessia Nidegger, Jan Hugo, Asfandyar Mufti, Athina-Ioanna Daponte, Laetitia Teixeira, Anna Balato, Marco Romanelli, Francesca Prignano, Spyridon Gkalpakiotis, Curdin Conrad, Elizabeth Lazaridou, Natalia Rompoti, Alexander J Stratigos, Miguel Nogueira, Ketty Peris, Tiago Torres
Age affects drug survival rates of interleukin (IL)-17 and IL-23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi-country, cohort study. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Natalia Rompoti, Irene Stefanaki, Pantelis Panagakis, Marina Papoutsaki, Maria Politou, Charitomeni Vavouli, Angeliki Befon, Fiori Kousta, Eleni Lazou, Maria Zaimi, Ioannis-Alexios Koumprentziotis, Vasiliki Chasapi, Dimitrios Rigopoulos, Alexander Stratigos, Electra Nicolaidou
Real-world effectiveness, drug survival and safety of risankizumab over a period of 2 years in 158 patients with moderate-to-severe plaque psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Natalia Rompoti, Theognosia Vergou, Irene Stefanaki, Charitomeni Vavouli, Ioannis-Alexios Koumprentziotis, Pantelis Panagakis, Marina Papoutsaki, Maria Politou, Angeliki Befon, Fiori Kousta, Eleni Lazou, Maria Zaimi, Vasiliki Chasapi, Alexander Stratigos, Electra Nicolaidou
Real-world effectiveness and drug survival of guselkumab over a period of 3 years in moderate-to-severe plaque psoriasis, including difficult-to-treat areas. International journal of dermatology (2024)
Natalia Rompoti, Maria Politou, Irene Stefanaki, Charitomeni Vavouli, Marina Papoutsaki, Afroditi Neofotistou, Dimitrios Rigopoulos, Alexander Stratigos, Electra Nicolaidou
Brodalumab in plaque psoriasis: Real-world data on effectiveness, safety and clinical predictive factors of initial response and drug survival over a period of 104 weeks. Journal of the European Academy of Dermatology and Venereology : JEADV 37 (4) (2023)
Natalia Rompoti, Maria Politou, Irene Stefanaki, Charitomeni Vavouli, Marina Papoutsaki, Afroditi Neofotistou, Dimitrios Rigopoulos, Alexander Stratigos, Electra Nicolaidou
Brodalumab in plaque psoriasis: Real-world data on effectiveness, safety and clinical predictive factors of initial response and drug survival over a period of 104 weeks. Journal of the European Academy of Dermatology and Venereology : JEADV 37 (4) (2023)
Natalia Rompoti, Maria Politou, Irene Stefanaki, Charitomeni Vavouli, Marina Papoutsaki, Afroditi Neofotistou, Dimitrios Rigopoulos, Alexander Stratigos, Electra Nicolaidou
Brodalumab in plaque psoriasis: real world data on effectiveness, safety, and clinical predictive factors of initial response and drug survival over a period of 104 weeks. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Dimitrios Rigopoulos, Natalia Rompoti, Aikaterini Tsiogka, Shari R Lipner
How to choose a systemic treatment for moderate-to-severe nail psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (12) (2022)
Natalia Rompoti, Maria Politou, Irene Stefanaki, Charitomeni Vavouli, Marina Papoutsaki, Afroditi Neofotistou, Dimitrios Rigopoulos, Alexander Stratigos, Electra Nicolaidou
Brodalumab in plaque psoriasis: Real-world data on effectiveness, safety and clinical predictive factors of initial response and drug survival over a period of 104 weeks. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Natalia Rompoti, Polytimi Sidiropoulou, P Panagakis, A Stratigos, M Papoutsaki, E Stefanaki, C Vavouli, M Politou, A Befon, P Kostakis, D Rigopoulos, E Nicolaidou
Real-world data from a single Greek centre on the use of secukinumab in plaque psoriasis: effectiveness, safety, drug survival, and identification of patients that sustain optimal response. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (6) (2020)
Stamatios Gregoriou, Polytimi Sidiropoulou, A Tsimpidakis, Natalia Rompoti, T Tsironi, P Panagakis, D Polydorou, P Kostakis, D Rigopoulos
Treatment of nail psoriasis with calcipotriol/betamethasone dipropionate foam versus pulse dye laser: an unblinded, intra-patient, left-to-right prospective study. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (9) (2020)
Natalia Rompoti, Pelagia Katsimbri, Georgios Kokkalis, Dimitrios Boumpas, Ignatios Ikonomidis, Konstantinos Theodoropoulos, Dimitris Rigopoulos, Evangelia Papadavid
Real world data from the use of secukinumab in the treatment of moderate-to-severe psoriasis, including scalp and palmoplantar psoriasis: A 104-week clinical study. Dermatologic therapy 32 (5) (2019)

Natalia Rompoti.css-eqlu8i{font-size:small;padding-left:4px;} (N Rompoti)

Publication Activity (10 Years)

Top Topics

Top Venues

Natalia Rompoti (N Rompoti)